Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for Other Vaccines in Central Africa has been steadily increasing in recent years.
Customer preferences: Central African customers have become more aware of the importance of vaccination in preventing diseases. As a result, they have been more willing to invest in Other Vaccines to protect themselves and their families. Additionally, with the rise in international travel, there has been a growing demand for vaccines that protect against diseases that are prevalent in other parts of the world.
Trends in the market: The Other Vaccines market in Central Africa has been growing at a steady pace. This growth can be attributed to various factors, such as the increasing awareness of the importance of vaccination, the rise in international travel, and the growing population in the region. Additionally, there has been a trend towards the development of more effective and efficient vaccines. This has led to the introduction of new and improved vaccines that are more effective in preventing diseases.
Local special circumstances: Central Africa is a region that is prone to outbreaks of infectious diseases. This has led to a greater emphasis on vaccination as a means of preventing the spread of these diseases. Additionally, the region has a large population of young children who are particularly vulnerable to infectious diseases. As a result, there has been a focus on increasing vaccination rates among this population.
Underlying macroeconomic factors: The economic development of Central Africa has been slow in recent years. This has led to a lack of investment in the healthcare sector, which has resulted in a shortage of healthcare facilities and personnel. However, there has been a growing recognition of the importance of healthcare in promoting economic development. This has led to an increase in investment in the healthcare sector, including the development and distribution of vaccines. Additionally, international organizations have been providing support to the healthcare sector in Central Africa, which has helped to drive the growth of the Other Vaccines market in the region.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
